119 related articles for article (PubMed ID: 19106503)
1. [Clinical significance of chemotherapy and chemo-radiotherapy in patients with metastatic esophageal cancer].
Mitsuhashi T; Miyazaki T; Sakimoto T; Kubo N; Ishiguro T; Okada N; Yokoyama M; Ishibashi K; Matsuki M; Takahashi T; Ishida H
Gan To Kagaku Ryoho; 2008 Nov; 35(12):1999-2001. PubMed ID: 19106503
[TBL] [Abstract][Full Text] [Related]
2. Baseline nutritional status is predictive of response to treatment and survival in patients treated by definitive chemoradiotherapy for a locally advanced esophageal cancer.
Di Fiore F; Lecleire S; Pop D; Rigal O; Hamidou H; Paillot B; Ducrotté P; Lerebours E; Michel P
Am J Gastroenterol; 2007 Nov; 102(11):2557-63. PubMed ID: 17680847
[TBL] [Abstract][Full Text] [Related]
3. Prospective comparison of surgery alone and chemoradiotherapy with selective surgery in resectable squamous cell carcinoma of the esophagus.
Ariga H; Nemoto K; Miyazaki S; Yoshioka T; Ogawa Y; Sakayauchi T; Jingu K; Miyata G; Onodera K; Ichikawa H; Kamei T; Kato S; Ishioka C; Satomi S; Yamada S
Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):348-56. PubMed ID: 19735862
[TBL] [Abstract][Full Text] [Related]
4. Nonoperable patients with superficial esophageal cancer treated by photodynamic therapy after chemoradiotherapy have more severe complications than patients treated in primary intent.
Lecleire S; Di Fiore F; Antonietti M; Ben-Soussan E; Hochain P; Lerebours E; Michel P; Ducrotté P
Am J Gastroenterol; 2008 Sep; 103(9):2215-9. PubMed ID: 18844614
[TBL] [Abstract][Full Text] [Related]
5. Preoperative versus postoperative chemoradiotherapy in the trimodality management of esophageal cancer.
Kim C; Monjazeb AM; Suntharalingam M; Giesinger KR; Blackstock AW
Clin Adv Hematol Oncol; 2009 May; 7(5):327-333, 342. PubMed ID: 19521322
[TBL] [Abstract][Full Text] [Related]
6. Radiation therapy for esophageal cancer in Japan: results of the Patterns of Care Study 1999-2001.
Kenjo M; Uno T; Murakami Y; Nagata Y; Oguchi M; Saito S; Numasaki H; Teshima T; Mitsumori M
Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):357-63. PubMed ID: 19735863
[TBL] [Abstract][Full Text] [Related]
7. Myelotoxicity of preoperative chemoradiotherapy is a significant determinant of poor prognosis in patients with T4 esophageal cancer.
Miyoshi N; Yano M; Takachi K; Kishi K; Noura S; Eguchi H; Yamada T; Miyashiro I; Ohue M; Ohigashi H; Sasaki Y; Ishikawa O; Doki Y; Imaoka S
J Surg Oncol; 2009 Apr; 99(5):302-6. PubMed ID: 19170110
[TBL] [Abstract][Full Text] [Related]
8. [Chemotherapy after second-line chemotherapy for patients with advanced or metastatic breast cancer].
Ogasawara Y; Doihara H; Takahashi M; Kawasaki K; Taira N
Gan To Kagaku Ryoho; 2008 Oct; 35(10):1713-6. PubMed ID: 18931574
[TBL] [Abstract][Full Text] [Related]
9. Radiation and chemotherapy in the treatment of esophageal cancer.
Diehl LF
Gastroenterol Clin North Am; 1991 Dec; 20(4):765-74. PubMed ID: 1787012
[TBL] [Abstract][Full Text] [Related]
10. Favourable outcomes of patients with clinical stage T3N0M0 bladder cancer treated with induction low-dose chemo-radiotherapy plus partial or radical cystectomy vs immediate radical cystectomy: a single-institutional retrospective comparative study.
Koga F; Kihara K; Fujii Y; Yoshida S; Saito K; Masuda H; Kageyama Y; Kawakami S
BJU Int; 2009 Jul; 104(2):189-94. PubMed ID: 19154452
[TBL] [Abstract][Full Text] [Related]
11. [Chemotherapy of esophageal carcinoma].
Herrmann R
Schweiz Med Wochenschr; 1993 May; 123(21):1103-5. PubMed ID: 8511542
[TBL] [Abstract][Full Text] [Related]
12. Comparison of radiation therapy alone and concurrent chemoradiation therapy in stage III cervical cancer: a multicenter retrospective study.
Lee JM; Tong SY; Lee KB; Kim YT; Kim YJ; Kim JW; Kim SM; Cho CH; Kim KT; Cho YL; Lee KC
Acta Obstet Gynecol Scand; 2009; 88(6):707-12. PubMed ID: 19353334
[TBL] [Abstract][Full Text] [Related]
13. A fractal dimension analysis: a new method for evaluating the response of anticancer therapy.
Omori H; Nio Y; Yano S; Itakura M; Koike M; Toga T; Matsuura S
Anticancer Res; 2002; 22(4):2347-54. PubMed ID: 12174925
[TBL] [Abstract][Full Text] [Related]
14. Survival impact of integrative cancer care in advanced metastatic breast cancer.
Block KI; Gyllenhaal C; Tripathy D; Freels S; Mead MN; Block PB; Steinmann WC; Newman RA; Shoham J
Breast J; 2009; 15(4):357-66. PubMed ID: 19470134
[TBL] [Abstract][Full Text] [Related]
15. Preoperative chemoradiotherapy for esophageal cancer: factors associated with clinical response and postoperative complications.
Morita M; Masuda T; Okada S; Yoshinaga K; Saeki H; Tokunaga E; Endo K; Emi Y; Kakeji Y; Maehara Y
Anticancer Res; 2009 Jul; 29(7):2555-62. PubMed ID: 19596928
[TBL] [Abstract][Full Text] [Related]
16. Colorectal cancer metastatic to the brain: time trends in presentation and outcome.
Nieder C; Pawinski A; Balteskard L
Oncology; 2009; 76(5):369-74. PubMed ID: 19321946
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of occult axillary lymph node metastases after chemotherapy-induced pathologic complete response of cytologically proven axillary lymph node metastases from breast cancer.
Loya A; Guray M; Hennessy BT; Middleton LP; Buchholz TA; Valero V; Sahin AA
Cancer; 2009 Apr; 115(8):1605-12. PubMed ID: 19197997
[TBL] [Abstract][Full Text] [Related]
18. A retrospective comparison of clinical outcomes and quality of life measures between definitive chemoradiation alone and radical surgery for clinical stage II-III esophageal carcinoma.
Yamashita H; Okuma K; Seto Y; Mori K; Kobayashi S; Wakui R; Ohtomo K; Nakagawa K
J Surg Oncol; 2009 Nov; 100(6):435-41. PubMed ID: 19653240
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of patients with stage III nonsmall cell lung cancer treated with chemotherapy and radiation with and without surgery.
Caglar HB; Baldini EH; Othus M; Rabin MS; Bueno R; Sugarbaker DJ; Mentzer SJ; Jänne PA; Johnson BE; Allen AM
Cancer; 2009 Sep; 115(18):4156-66. PubMed ID: 19551884
[TBL] [Abstract][Full Text] [Related]
20. Salvage esophagectomy after definitive chemoradiotherapy for thoracic esophageal cancer.
Miyata H; Yamasaki M; Takiguchi S; Nakajima K; Fujiwara Y; Nishida T; Mori M; Doki Y
J Surg Oncol; 2009 Nov; 100(6):442-6. PubMed ID: 19653262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
